ADVERTISEMENT
Posted: Mar 7, 2023

Fentanyl-based OUD guidance needed in light of crisis

Fentanyl

The latest CDC data find that deaths involving synthetic opioids like fentanyl increased by a staggering 80% over the past 2 years. These drugs were involved in more than two-thirds of the overdose deaths in the year ending March 2022.

Loren Bonner

Read more
Posted: Mar 7, 2023

Overlapping gabapentin and opioid prescriptions have been on the rise

Gabapentin

Ninety-five percent of gabapentin prescriptions are written for off-label pain management, despite studies questioning gabapentin’s effectiveness for managing pain, and reports of its misuse with simultaneous opioid therapy.

Loren Bonner

Read more
Posted: Mar 7, 2023

Interruption or continuation of antithrombotic therapy in perioperative patients?

Antithrombotics

Too often, clinicians question whether they are making the right decision about a patient’s anticoagulation therapy with planned, nonemergent surgical procedures.

Ariel L. Clark, PharmD

Read more
Posted: Feb 7, 2023

New Drugs

New & Approved

Updates from FDA

Read more
Posted: Feb 7, 2023

Rein in headache pain

OTCs Today

Headaches are a common complaint among patients of all ages, with women nearly twice as likely as men to have had a severe headache or migraine in the past 3 months.

Mary Warner

Read more
First4041424345474849Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT